Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Director departure
Inv. presentation
Quarterly results
Consulting agrmnt
Appointed COO
Appointed director
CC transcript
BIOGEN INC. (BIIB) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 8-K/A Quarterly results
09/28/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/26/2023 8-K Quarterly results
08/07/2023 SC 13D BIOGEN INC. reports a 23.4% stake in REATA PHARMACEUTICALS, INC.
07/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/31/2023 8-K Quarterly results
07/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/28/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Biogen to Acquire Reata Pharmaceuticals",
"Investor Webcast Presentation, prepared by the Company"
07/25/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/25/2023 8-K Quarterly results
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/29/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
06/13/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/13/2023 DEFR14A Form DEFR14A - Revised definitive proxy soliciting materials:
06/12/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/03/2023 8-K Quarterly results
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 144 Form 144 - Report of proposed sale of securities:
04/25/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/25/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
04/04/2023 144 Form 144 - Report of proposed sale of securities:
03/28/2023 144 Form 144 - Report of proposed sale of securities:
02/09/2023 SC 13G/A PRIMECAP MANAGEMENT CO reports a 10.9% stake in Biogen Inc.
01/27/2023 5 Posner Brian S (Director) has filed a Form 5 on BIOGEN INC.
01/27/2023 5 SHERWIN STEPHEN A (Director) has filed a Form 5 on BIOGEN INC.
01/24/2023 SC 13G/A BlackRock Inc. reports a 9.9% stake in BIOGEN INC
11/10/2022 8-K Quarterly results
10/25/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/25/2022 8-K Quarterly results
07/20/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/20/2022 8-K/A Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy